Occurrence of Gastrointestinal (GI) Side Effects upon GLP-1 Receptor Agonist (GLP-1RA) Initiation with Concomitant Metformin Use

被引：0
|
作者：
Klein, Klara R.
Clemmensen, Kim K. B.
Fong, Edwin
Olsen, Soren
Abrahamsen, Trine J.
Lingvay, Ildiko
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-780-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Acute Metabolic Effects of MEDI0382, a GLP-1/Glucagon Dual Agonist, in Wild Type and GLP-1 Receptor Knockout (GLP-1RKO) Mice
    Will, Sarah E.
    Naylor, Jacqueline
    Rossi, Alessandra
    Hornigold, David
    Oldham, Stephanie
    Trevaskis, James
    Konkar, Anish
    DIABETES, 2016, 65 : A35 - A35
  • [42] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [43] The use of GLP-1 agonist liraglutide: adhering to guidelines?
    Fatima, J.
    Pearce, S.
    DIABETIC MEDICINE, 2014, 31 : 74 - 74
  • [44] Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder
    Klausen, Mette Kruse
    Knudsen, Gitte Moos
    Vilsboll, Tina
    Fink-Jensen, Anders
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2025, 136 (03)
  • [45] Association Between Gastrointestinal Disorders Due to GLP-1 Receptor Agonist and Autonomic Neuropathy
    Obatake, Azusa
    Ito, Naoko
    Yagi, Kunimasa
    Kobayashi, Junji
    Matsumoto, Yuuki
    Okazaki, Satoko
    Nakano, Kaoru
    Takeda, Yoshiyu
    Yamagishi, Masakazu
    DIABETES, 2012, 61 : A572 - A572
  • [46] Efficacy and safety of IDegLira (combination of insulin degludec plus liraglutide), in insulin-naive patients with type 2 diabetes uncontrolled on GLP-1 receptor agonist (GLP-1RA) therapy
    Linjawi, S.
    Bode, B. W.
    Chaykin, L. B.
    Courreges, J. -P.
    Handelsman, Y.
    Lehmann, L. M.
    Mishra, A.
    Simpson, R. W.
    DIABETOLOGIA, 2015, 58 : S401 - S402
  • [47] Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist
    Gentinetta, Silvia
    Sottotetti, Francesca
    Manuelli, Matteo
    Cena, Hellas
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 4817 - 4824
  • [48] GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
    Valeria Guglielmi
    Paolo Sbraccia
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2017, 22 : 231 - 240
  • [49] GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
    Guglielmi, Valeria
    Sbraccia, Paolo
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2017, 22 (02) : 231 - 240
  • [50] The Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (GLP-1RA) on Postprandial Glucagon Secretion Independent of the Gastric Emptying Rate
    Frandsen, Christian S.
    Ostergaard, Lauge
    Dejgaard, Thomas F.
    Sondergaard, Bo
    Holst, Jens J.
    Madsbad, Sten
    DIABETES, 2016, 65 : A278 - A278
12345